GREENGARD; Paul

Patent Applications and Registrations

Patent applications and USPTO patent grants for GREENGARD; Paul.The latest application filed is for "compositions and methods for modulating neuronal excitability and motor behavior".

Company Profile

3.29.31

GREENGARD; Paul - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Modulating Neuronal Excitability And Motor Behavior App 20210317451 - SCHAEFER; Anne ; et al.	2021-10-14
Methods and compositions for translational profiling and molecular phenotyping Grant 10,947,546 - Heintz , et al. March 16, 2	2021-03-16
Compositions and methods for modulating neuronal excitability and motor behavior Grant 10,870,853 - Schaefer , et al. December 22, 2	2020-12-22
Treatment of neurodegenerative diseases through inhibition of HSP90 Grant 10,336,757 - Chiosis , et al.	2019-07-02
Compositions And Methods For Modulating Neuronal Excitability And Motor Behavior App 20190144858 - SCHAEFER; Anne ; et al.	2019-05-16
Compositions and methods for modulating neuronal excitability and motor behavior Grant 10,087,443 - Schaefer , et al. October 2, 2	2018-10-02
Methods And Compositions For Translational Profiling And Molecular Phenotyping App 20180155728 - Heintz; Nathanial ; et al.	2018-06-07
Methods and compositions for translational profiling and molecular phenotyping Grant 9,816,096 - Heintz , et al. November 14, 2	2017-11-14
Regulatory proteins and inhibitors Grant 9,605,041 - Greengard , et al. March 28, 2	2017-03-28
Methods for the treatment of A-.beta. related disorders and compositions therefor Grant 9,532,980 - Flajolet , et al. January 3, 2	2017-01-03
Compositions And Methods For Modulating Neuronal Excitability And Motor Behavior App 20160244757 - SCHAEFER; Anne ; et al.	2016-08-25
Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain Grant 9,157,906 - Greengard , et al. October 13, 2	2015-10-13
Methods And Compositions For Translational Profiling And Molecular Phenotyping App 20150082470 - HEINTZ; Nathaniel ; et al.	2015-03-19
Novel Therapeutic And Diagnostic Products And Methods App 20150071858 - SVENNINGSSON; Per ; et al.	2015-03-12
Combination Medicine For Treatment Of Depression App 20140107104 - Nishi; Akinori ; et al.	2014-04-17
Novel Therapeutic And Diagnostic Products And Methods App 20130330740 - SVENNINGSSON; Per ; et al.	2013-12-12
Compositions and methods for prevention and treatment of amyloid-.beta. peptide-related disorders Grant 8,598,171 - Netzer , et al. December 3, 2	2013-12-03
Phosphodiesterase Activity And Regulation Of Phosphodiesterase 1b-mediated Signaling In Brain App 20130239234 - Greengard; Paul ; et al.	2013-09-12
Diagnosis of depression Grant 8,470,548 - Svenningsson , et al. June 25, 2	2013-06-25
Novel Regulatory Proteins And Inhibitors App 20130149309 - Greengard; Paul ; et al.	2013-06-13
Novel Therapeutic And Diagnostic Products And Methods App 20120178797 - SVENNINGSSON; Per ; et al.	2012-07-12
Compositions And Methods For Prevention And Treatment Of Amyloid-beta Peptide-related Disorders App 20110312093 - NETZER; William ; et al.	2011-12-22
Methods And Compositions For Translational Profiling And Molecular Phenotyping App 20110071049 - Heintz; Nathaniel ; et al.	2011-03-24
Compositions and methods for prevention and treatment of amyloid-.beta. peptide-related disorders Grant 7,910,586 - Netzer , et al. March 22, 2	2011-03-22
Novel therapeutic and diagnostic products and methods App 20100162422 - Svenningsson; Per ; et al.	2010-06-24
Methods For The Treatment Of A-beta Related Disorders And Compositions Therefor App 20100143361 - Flajolet; Marc ; et al.	2010-06-10
Treatment of Neurodegenerative Diseases Through Inhibition of HSP90 App 20090298857 - Chiosis; Gabriela ; et al.	2009-12-03
Compositions And Methods For Inhibiting Gsk3 Activity And Uses Thereof App 20090233993 - Xu; Huaxi ; et al.	2009-09-17
Method for classification of anti-psychotic drugs Grant 7,427,485 - Greengard , et al. September 23, 2	2008-09-23
Compositions and methods for regulation of calcium-dependent signaling in brain App 20080193964 - Greengard; Paul ; et al.	2008-08-14
Phosphodiesterase acitvity and regulation of phosphodiesterase 1-B-mediated signaling in brain App 20080176961 - Greengard; Paul ; et al.	2008-07-24
Compositions and methods for modulation of DARPP-32 phosphorylation Grant 7,320,785 - Greengard , et al. January 22, 2	2008-01-22
Indirubin-Type Compounds, Compositions, and Methods for Their Use App 20070276025 - Meijer; Laurent ; et al.	2007-11-29
Regulation of neuronal function through metabotropic glutamate receptor signaling pathways Grant 7,129,073 - Liu , et al. October 31, 2	2006-10-31
Regulation Of Neuronal Function Through Metabotropic Glutamate Receptor Signaling Pathways App 20060223158 - Liu; Feng ; et al.	2006-10-05
Methods of treating dopamine dysregulation using agents that regulate phosphorylation/dephosphorylation in dopamine signaling Grant 6,989,362 - Bibb , et al. January 24, 2	2006-01-24
Compositions and method for regulation of calcium-dependent signaling in brain App 20050153372 - Greengard, Paul ; et al.	2005-07-14
Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders App 20040028673 - Netzer, William ; et al.	2004-02-12
Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain App 20030211040 - Greengard, Paul ; et al.	2003-11-13
Compositions and methods for modulation of DARPP-32 phosphorylation App 20030171255 - Greengard, Paul ; et al.	2003-09-11
Method for classification of anti-psychotic drugs App 20030109419 - Greengard, Paul ; et al.	2003-06-12
DNA encoding the human synapsin III gene and uses thereof App 20030082645 - Greengard, Paul ; et al.	2003-05-01
DNA encoding the human synapsin III gene and uses thereof Grant 6,429,010 - Greengard , et al. August 6, 2	2002-08-06
Dna Encoding The Human Synapsin Iii Gene And Uses Thereof App 20020064811 - GREENGARD, PAUL ; et al.	2002-05-30
Method of treating psychosis and/or hyperactivity Grant 6,013,621 - Nishi , et al. January 11, 2	2000-01-11
Treatment and prevention of neurodegenerative diseases using modulators of Fe65 Grant 5,928,882 - Sabo , et al. July 27, 1	1999-07-27
Knockout mutant mouse for DARPP-32 and use thereof Grant 5,777,195 - Fienberg , et al. July 7, 1	1998-07-07
Method of treating amyloidosis by modulation of calcium Grant 5,538,983 - Buxbaum , et al. July 23, 1	1996-07-23
Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation Grant 5,385,915 - Buxbaum , et al. January 31, 1	1995-01-31
Treatment of amyloidosis associated with Alzheimer disease Grant 5,242,932 - Gandy , et al. September 7, 1	1993-09-07
Use of phosphoprotein patterns for diagnosis of neurological and psychiatric disorders Grant 4,874,694 - Gandy , et al. October 17, 1	1989-10-17

Company Registrations

SEC

0001585671

Greengard Paul

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.